Statin use appears to be associated with a lower risk of renal cell carcinoma (RCC) in women without a history of hypertension, according to a small analysis from researchers in Boston. When compared with those who did not take statins, the overall multivariate relative risks for RCC were 0.68 for men and 1.17 for women who took statins.
Abstract: Cancer, February 2012.
